Skip to main content
. Author manuscript; available in PMC: 2007 Oct 21.
Published in final edited form as: Endocrinology. 2005 Aug 11;146(11):4887–4897. doi: 10.1210/en.2005-0572

Fig. 2.

Fig. 2

P0 and normalized P0/CSA in different treatment groups (n = 7–8). Data are presented as mean ± sd. *, P < 0.05, compared with the intact control group. #, P < 0.05, compared with the vehicle (Veh)-treated ORX group.